chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Menstrual disorder, Nausea, SARS-CoV-2 test
Clinical narrative: diarrhea; nausea; Occurred at same time as menstrual period, so probably not related but I figured; This is a spontaneous report from a non-contactable other health professional. A 28-year-old non pregnant female patient received bnt162b2 (BNT162B2, Formulation: solution for injection Batch/Lot number: EL3248, expiration date not provided), via unknown route of administration, administered in Arm Left on 05Feb2021 14:30, as DOSE 2, SINGLE (at the age of 28-year-old) for covid-19 immunisation. The patient medical history was not reported. Patient had not received any other vaccine within 4 weeks. Concomitant medications included spironolactone, sertraline HCL and amfetamine (ADZENYS XR ODT) taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. The patient reported that she had menstrual period on the same time so probably not related but she figured she might as well report it anyway on 05Feb2021. Beginning a couple days after second vaccine, the patient experienced persistent diarrhea and nausea on 07Feb2021. The patient underwent lab tests which included sars-cov-2 test: negative on 05Feb2021. The outcome of event menstrual period was unknown other events as recovered on 09Feb2021.   No follow-up attempts are possible. No further information is expected  .
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Severe arm pain with limited mobility; Severe arm pain with limited mobility; This is a spontaneous report from a non-contactable consumer(patient) or other non hcp. A 62-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247) via an unspecified route of administration on 17Feb2021 (at the age of 62-year-old) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive COVID prior vaccination and was not tested for COVID-19. The patient experienced severe arm pain with limited mobility on 17Feb2021. Therapeutic measures were taken as a result of severe arm pain with limited mobility with Acetaminophen 650mg. Outcome of the events was unknown.   No follow up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity
Clinical narrative: Headache; Sore arm; Minor body aches; This is a spontaneous report from a contactable consumer (patient). A 23-years-old non-pregnant female patient received 2nd dose of BNT162B2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in right arm on 17Feb2021 at 14:45, at workplace clinic as dose 2, single (age at vaccination: 23 years) for covid-19 immunisation. Medical history included polycystic ovaries and milk allergy. Concomitant medications included metformin, spironolactone, buspirone and ethinylestradiol, levonorgestrel (CAMRESE). Historical vaccine included patient received first dose of BNT162B2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in right arm on 27Jan2021 at 14:45 as dose 1, single for covid-19 immunisation. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and post the vaccination, the patient was not tested for COVID-19. On 17Feb2021 02:45 PM, the patient experienced headache, sore arm (pain in extremity) and minor body aches (pain). No treatment was taken as a result of the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Breast swelling
Clinical narrative: Breast were swollen; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown, Expiry date: unknown), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced breast were swollen on an unspecified date. The patient wanted to know if second shot can be taken when breast were swollen. The outcome of event was unknown.   Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: her arm is a little bit painful.; This is a spontaneous report. A contactable female consumer(patient) reported that:   A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on 15Feb2021 at dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 15Feb2021, the patient experienced her arm is a little bit painful. At the time of reporting, the outcome of the event was unknown.   Follow-up attempts completed. No further information expected.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fear of injection
Clinical narrative: I am scared; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) (at the age of 78-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated that he had his COVID vaccine and would get second shot on 05Mar2021, but he was scared. Outcome of the event was unknown.  Follow-up attempts completed. No further information expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Upper respiratory tract infection
Clinical narrative: Slight to mild sore throat, followed by slight to mild cough (getting worse at the moment).; followed by slight to mild cough (getting worse at the moment); upper respiratory tract infection; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (at the age of 58 years old) via an unspecified route of administration, administered in Arm Left on 22Feb2021 11:00 (Batch/Lot Number: EL3247) as dose 1, single for covid-19 immunisation. Medical history included allergic to rabbits and cats. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included naproxen (took one about a week before vaccination) and paracetamol (ACETAMINOFEN GENFAR). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced slight to mild sore throat, followed by slight to mild cough on 24Feb2021 22:00 which was getting worse at the moment. The patient guessed that he got an unrelated upper respiratory tract infection, but just a guess. The events were not treated. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Dizziness, Fatigue, Hangover
Clinical narrative: Flu-like; Bad hangover; Fatigue; Malaise; Nausea; Stomach pain; Body aches; Chills; Sore arm on side of injection; Axillary lymphadenopathy; Light-headedness; Headache; This is a spontaneous report from a non-contactable other Healthcare Professional (patient) reported for herself. A 20-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6200, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 17Feb2021 at 15:45 pm (age at vaccination was 20 years) as dose 1, single for COVID-19 immunization. The patient's medical history included COVID-19 from an unknown date. The patient did not have any known allergies. Concomitant medication included spironolactone taken for an unspecified indication. The patient previously took flu vaccine and had minor local reaction to flu vaccine annually. The facility where the most recent COVID-19 vaccine was administered was Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 18Feb2021 at 04:00 am, the patient experienced flu-like, bad hangover, fatigue, malaise, nausea, stomach pain, body aches, chills (no fever), sore arm on side of injection, axillary lymphadenopathy, light-headedness and headache. All symptoms onset was in the morning after vaccination (about 12 hours later) and were improving 24 hours after symptom onset. No treatment was received for the adverse events. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab test which included COVID-19 PCR test (nasal swab): negative on 18Feb2021. The outcome of the events was resolving.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Lymphadenopathy, Malaise, Nausea
Clinical narrative: Flu-like; Bad hangover; Fatigue; Malaise; Nausea; Stomach pain; Body aches; Chills; Sore arm on side of injection; Axillary lymphadenopathy; Light-headedness; Headache; This is a spontaneous report from a non-contactable other Healthcare Professional (patient) reported for herself. A 20-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6200, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 17Feb2021 at 15:45 pm (age at vaccination was 20 years) as dose 1, single for COVID-19 immunization. The patient's medical history included COVID-19 from an unknown date. The patient did not have any known allergies. Concomitant medication included spironolactone taken for an unspecified indication. The patient previously took flu vaccine and had minor local reaction to flu vaccine annually. The facility where the most recent COVID-19 vaccine was administered was Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 18Feb2021 at 04:00 am, the patient experienced flu-like, bad hangover, fatigue, malaise, nausea, stomach pain, body aches, chills (no fever), sore arm on side of injection, axillary lymphadenopathy, light-headedness and headache. All symptoms onset was in the morning after vaccination (about 12 hours later) and were improving 24 hours after symptom onset. No treatment was received for the adverse events. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab test which included COVID-19 PCR test (nasal swab): negative on 18Feb2021. The outcome of the events was resolving.   No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Flu-like; Bad hangover; Fatigue; Malaise; Nausea; Stomach pain; Body aches; Chills; Sore arm on side of injection; Axillary lymphadenopathy; Light-headedness; Headache; This is a spontaneous report from a non-contactable other Healthcare Professional (patient) reported for herself. A 20-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6200, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 17Feb2021 at 15:45 pm (age at vaccination was 20 years) as dose 1, single for COVID-19 immunization. The patient's medical history included COVID-19 from an unknown date. The patient did not have any known allergies. Concomitant medication included spironolactone taken for an unspecified indication. The patient previously took flu vaccine and had minor local reaction to flu vaccine annually. The facility where the most recent COVID-19 vaccine was administered was Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 18Feb2021 at 04:00 am, the patient experienced flu-like, bad hangover, fatigue, malaise, nausea, stomach pain, body aches, chills (no fever), sore arm on side of injection, axillary lymphadenopathy, light-headedness and headache. All symptoms onset was in the morning after vaccination (about 12 hours later) and were improving 24 hours after symptom onset. No treatment was received for the adverse events. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab test which included COVID-19 PCR test (nasal swab): negative on 18Feb2021. The outcome of the events was resolving.   No follow-up attempts are possible. No further information is expected.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in the shoulder blade at the injection site arm; This is a spontaneous report from a contactable consumer (patient's daughter). A 94-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 16Feb2021 (Batch/Lot number was not reported) (at the age of 94-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included flu vaccine, shingles vaccine and pneumonia vaccine with no side effects. The patient experienced pain in the shoulder blade at the injection site arm on 17Feb2021 with outcome of unknown. It was reported that on 16Feb2021 the patient received her first dose of the Pfizer covid vaccine and the next day she stated experiencing pain in the shoulder blade at the injection site arm. The reporter wanted to know about it and mentioned that she was disappointed that her mother (patient) experienced this side effect. It was mentioned that the patient tolerated flu, shingles, and pneumonia vaccine with no side effects. It was added that the patient got the first vaccine on 16Feb2021. She was ok until the next day. She started complaining the following day of pain in her shoulder blade on the same side as the injection site which was the left arm. It has been over a week and she was still complaining about it. The reporter mentioned that she knows some of the side effects are typical muscle aches, pains, and headaches, the same as the flu shot. It had been going on for too long and the reporter was concerned. The patient had been taking TYLENOL on and off, but not consistently because she doesn't want to take needless medication if it was not really bothering her. The patient has had no other side effects. No fever, no aches elsewhere, and no headache. The reporter asked if this was a typical reaction for this vaccine and if there had been reports before. The reporter was wondering if she should be really concerned. She mentioned that she doesn't like to see her mom (patient) in pain. She added that it was not a crippling type of pain where she can't function. She just has a sad face. Therapeutic measures were taken as a result of pain in the shoulder blade at the injection site arm.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenitis, Lymphadenopathy, Vaccination site pain
Clinical narrative: lymph nodes under the right cheek were inflamed and swollen; lymph nodes under the right cheek were inflamed and swollen; sore arm; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in arm Left on 21Feb2021 (Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had the shot on the left arm. On 22Feb2021, the next day after the vaccination, patient woke up with a sore arm. On 25Feb2021, patient's lymph nodes under the right cheek were inflamed and swollen, the right side below his jaw area was swollen. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Pyrexia, Taste disorder
Clinical narrative: change in taste; weak; fever with body temperature 102.9 Fahrenheit; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EN6200) via an unspecified route of administration, administered in left arm on 22Feb2021 as dose 2, single for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medication included hydrochlorothiazide (HYDROCHLOROTHIAZIDE). The patient previously took amoxicillin sodium;clavulanic acid (AUGMENTIN) and experienced drug allergy. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EL9262) on an unspecified date for COVID-19 immunisation. On an unspecified date, patient experienced change in taste and was weak. On Feb2021, patient had fever with body temperature 102.9 Fahrenheit. Outcome of event fever was recovered on an unspecified date while the outcome of all other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Body temperature, Laboratory test, Myalgia
Clinical narrative: elevated body temperature/fever; he has developed joint soreness; Muscle soreness; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 67-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 20Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization. Medical history was none. Concomitant medication(s) included colecalciferol (VITAMIN D) and cyanocobalamin (VITAMIN B 12) both taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the patient was asking if it would be normal to have an elevated body temperature or fever without him feeling that he has a fever. Patient had looks from 2 different government agencies that took peoples temperatures as precaution, they had to check his temperature twice but patient did not verify the temperature reading from those agencies. He is concerned since he would have to go to a nursing home to visit his relative and they are strict about the body temperature of visitors. On 28Feb2021, the patient has developed joint soreness and muscle soreness. The patient underwent lab tests and procedures which included blood test: blood work is clean in a good way, body temperature: elevated, and laboratory test: his labs are clean all on an unspecified date. Therapeutic measures were taken as a result of joint soreness and muscle soreness which includes took ginger tea and green tea and he felt noticeable relief. The 2nd dose of vaccine was scheduled on 13Mar2021. He is a healthy man, his blood work was beautiful. The outcome of the event elevated body temperature/fever was unknown, for the joint soreness was recovering while for muscle soreness was recovered.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: elevated body temperature/fever; he has developed joint soreness; Muscle soreness; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 67-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Left on 20Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunization. Medical history was none. Concomitant medication(s) included colecalciferol (VITAMIN D) and cyanocobalamin (VITAMIN B 12) both taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the patient was asking if it would be normal to have an elevated body temperature or fever without him feeling that he has a fever. Patient had looks from 2 different government agencies that took peoples temperatures as precaution, they had to check his temperature twice but patient did not verify the temperature reading from those agencies. He is concerned since he would have to go to a nursing home to visit his relative and they are strict about the body temperature of visitors. On 28Feb2021, the patient has developed joint soreness and muscle soreness. The patient underwent lab tests and procedures which included blood test: blood work is clean in a good way, body temperature: elevated, and laboratory test: his labs are clean all on an unspecified date. Therapeutic measures were taken as a result of joint soreness and muscle soreness which includes took ginger tea and green tea and he felt noticeable relief. The 2nd dose of vaccine was scheduled on 13Mar2021. He is a healthy man, his blood work was beautiful. The outcome of the event elevated body temperature/fever was unknown, for the joint soreness was recovering while for muscle soreness was recovered.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: he lost his sense of taste; This is a spontaneous report from a contactable consumer (patient) via the Pfizer sponsored program. An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 19Feb2021 (lot number: EL9266; expiry date: unknown) at the age of 85-years-old, as dose 1, single, in the left upper arm for Covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The patient reported that he lost his sense of taste on 20Feb2021. The patient mentioned that he received the 1st dose last Friday, 19Feb2021. On 20Feb2021, after a day or so later, he lost his sense of taste. He mentioned that it was coming back very slowly. He clarified that it was only about 10-15 percent back. He never had a COVID 19 test and showed no other symptoms for COVID-19 so he assumes he was not a victim. Patient would like to know if he should take his second shot. Second injection was scheduled on 12Mar2021. He stated that he can taste spicy things, but he cannot taste things that were not spicy. He can taste salt and pepper, but he cannot taste anything blander than that. Patient's height was between 5ft 9.5 in to 5ft 10 in, while his weight: was 185-190 lbs. Outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: have an allergic reaction on the skin of the entire body; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 10Feb2021 (lot number and expiry date: unknown) as dose 2, single, for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 for COVID-19 immunisation; and influenza vaccine which caused allergic reaction. On 22Feb2021, the patient experienced an allergic reaction on the skin of the entire body. It itched a lot and was reddish. She took an unspecified anti-allergy as treatment. She also had an allergic reaction to the flu vaccine before, but this time the allergic reaction was immediate, and she does not know if this allergy was a vaccine reaction or not. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: experiencing a runny nose; This is a spontaneous report from a contactable consumer (patient) communicated via Pfizer-sponsored program. A female patient of unspecified age received bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot number: not provided, expiration date not provided), via unknown route of administration, administered on an unknown date, as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medication was not provided. On an unknown date the patient experienced a runny nose. The patient wanted to confirm if she should take the second dose while experiencing a runny nose. Outcome of event was unknown.  Follow-up attempts completed. No further information expected.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: I have pain on the right shoulder (where I got my first vaccine). It's aching like the dickens; This is a spontaneous report from a contactable consumer.   An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 23Feb2021 (Batch/Lot number was not reported) as dose 2, single (at the age of 82 years old) for COVID-19 immunisation.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 on 29Jan2021 (Batch/Lot number was not reported) for COVID-19 immunisation. He received the first dose on 29Jan2021. It was given in his right shoulder. He did not have any problems with the first vaccine. The patient stated, "I had my 2nd one this past Tuesday on 23Feb2021 on my left shoulder. I have pain on the right shoulder (where I got my first vaccine). It's aching like the dickens. It's unusual and surprised it would show up so late. I'll have to call him tomorrow. I'll call. And its possible over night the pain may go away." The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Shooting pain in my neck; This is a spontaneous report from a non-contactable consumer (patient). A 31-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date were not reported) via an unspecified route of administration on 04Feb2021 (age at vaccination: 31-years-old) as dose number unknown, single for COVID-19 immunization (Workplace clinic). The patient medical history and concomitant medications were not reported. The patient had no allergies. On 04Feb2021, the patient had experienced shooting pain in my neck. The patient had not received any other vaccine within 4 weeks. The patient not received other medications in two weeks. Patient received no treatment for the event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the event was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: some mild symptoms similar to a common cold; This is a spontaneous report from non-contactable consumer (Nurse, patient, self-reported) via Pfizer Sales Representative. A female patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history included COVID-19 and lingering issues (with her sense of smell). Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. After receiving her second dose of the vaccine, she felt some mild symptoms similar to a common cold for a few days on an unspecified date. After this, she said that she felt better than she had since she contracted COVID-19. For months she had lingering malaise that she said seemed to go away after the second vaccine dose, she said that she felt better than she had since before getting Covid-19 last summer. Outcome of the event was recovering. No follow-up attempts are possible. No further information is expected
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Ocular hyperaemia
Clinical narrative: facial flushness; eyes got blood shot/ eye redness; This is a spontaneous report from a contactable consumer (patient's husband). A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, administered in left arm, on 21Feb2021 (at the age of 72 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 21Feb2021, it was reported that the patient experienced facial flushness, with eye redness that started immediately after the vaccine. The patient's eyes got blood shot and she had not heard of that, and queried if was that something new or a normal side effect. The outcome of the event was recovered on 21Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Blister, Skin disorder
Clinical narrative: Scalp blistered; scalp was burning; it has smell; Scalp blistered; scalp was burning; it has smell; This is a spontaneous report from a contactable consumer or other health care professional (patient). A 65-years-old female (non-pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Batch no: not reported/Lot Number: EL3248) via an unspecified route of administration on an unspecified date as dose number, unknown, single for covid-19 immunization. Medical history included Hashimoto's disease from an unknown date to unknown if ongoing. Concomitant medications included levothyroxine, omeprazole and Vitamin D Nos, all are taken for unspecified indication from an unknown date to unknown if ongoing. On 16Feb2021, the patient experienced scalp blistered, scalp was burning, it has smell. The outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Headache, Pyrexia
Clinical narrative: fatigue; fever/fever 100.2; Light-headed; headache; This is a spontaneous report from a contactable consumer or other non hcp.  A 67-year-old male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on 12Feb2021 (Batch/Lot Number: EL9267) as dose 2, single (at the age of 67 years old) for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 for COVID-19 immunisation and experienced after the first dose of the vaccine, 3 days after experienced fatigue and dizziness. And was on the sofa all day. The dizziness and fatigue lasted on and off for 2 days but not the same degree.  The patient stated on 22Feb2021, "The dizziness and fatigue lasted on and off for 2 days but not the same degree. The 2nd dose was very uneventful. But had some reaction yesterday which is 10 days after having the 2nd dose, little fever and very fatigued and better today. Is there any reports of delayed reactions, 9 or 10 days after?"  The patient underwent lab tests and procedures which included body temperature: 100.2 on 22Feb2021 and normal on an unspecified date.  The outcome of fatigue and fever was recovering and other events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia, Rash
Clinical narrative: Serum sickness potential; fever; body aches; rash; fatigue; headache; This is a spontaneous report from a contactable nurse (patient). A 49-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot Number: E19265; Expiration date was not reported), via an unspecified route of administration, administered in the left arm on an unspecified date in Jan2021 (with the reported time of 09:00 AM) (at the age of 49-years-old) as dose 1, single for COVID-19 immunisation. The patient has no medical history and no concomitant medication. The patient has no known allergies. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination. On 31Jan2021, the patient experienced serum sickness potential that was diagnosed by primary doctor, severe reaction , fever, body aches, rash, fatigue and headache. Events resulted in a doctor or other healthcare professional office/clinic visit and emergency room visit. Treatment with steroids, antibiotics and symptom management were taken as a result of the events. The patient underwent lab tests and procedures which included COVID-19 test (Nasal swab): Negative on 06Feb2021. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Serum sickness-like reaction
Clinical narrative: Serum sickness potential; fever; body aches; rash; fatigue; headache; This is a spontaneous report from a contactable nurse (patient). A 49-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot Number: E19265; Expiration date was not reported), via an unspecified route of administration, administered in the left arm on an unspecified date in Jan2021 (with the reported time of 09:00 AM) (at the age of 49-years-old) as dose 1, single for COVID-19 immunisation. The patient has no medical history and no concomitant medication. The patient has no known allergies. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination. On 31Jan2021, the patient experienced serum sickness potential that was diagnosed by primary doctor, severe reaction , fever, body aches, rash, fatigue and headache. Events resulted in a doctor or other healthcare professional office/clinic visit and emergency room visit. Treatment with steroids, antibiotics and symptom management were taken as a result of the events. The patient underwent lab tests and procedures which included COVID-19 test (Nasal swab): Negative on 06Feb2021. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Lymph node pain, Vaccination site pain
Clinical narrative: Fatigue; backache; aches in both knees; sore at injection site (left arm); tender/painful lymphnode under left armpit (site of injection); This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Lot Number: EN5318, Expiration Date not reported) via an unspecified route of administration, administered in the left arm on 20Feb2021 10:00 (at the age of 71-years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma, eczema, interstitial cystitis, prediabetes and scallop allergy. The patient previously took nickel and experienced allergy to metals; and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Lot Number: EN5318, Expiration Date not reported) via an unspecified route of administration, administered in the left arm on 30Jan2021 10:00 (at the age of 71-years-old) as dose 1, single for COVID-19 immunisation. The patient received unspecified concomitant medications within two weeks of receiving BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fatigue, backache, aches in both knees, sore at injection site (left arm), and tender/painful lymph node under left armpit (site of injection) on 20Feb2021 18:00. No treatment was received as a result of the events. The outcome of events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia, Vomiting
Clinical narrative: chills all day; I've had vomit; nausea; high fever; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 37; Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 24Feb2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on an unspecified date for COVID-19 immunisation. On 24Feb2021, the patient experienced chills all day, since then I've had vomit, nausea, chills and high fever. The outcome of the events was not recovered/not resolved.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: She stated she felt bad after the vaccine for a day; This is a spontaneous report from a non-contactable consumer (Patient herself) from a Pfizer-sponsored program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient stated she felt bad after the vaccine for a day. She didn't feel good for a day. The patient stated both patient and her husband got their 1st dose and were part of a recording thing and it would text them how they were feeling etc. Advised not sure what app or texting app they are using would need to reach out to health department. She thinks she hit stop because now they were getting nothing. Outcome of the event was recovered.  No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Dry eye, Eye contusion
Clinical narrative: Dryness of eyes; Black prints on eyes; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Feb2021 06:15 (at the age of 61-year-old) (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history included multiple issues following severe accident and known allergies: rubber. The patient's concomitant medications were not reported. The patient received any other medications within 2 weeks of vaccination but do know what. On an unspecified date, the patient experienced dryness of eyes and black prints on eyes. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for covid-19. Outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Fatigue, Flushing, Head discomfort, Myalgia
Clinical narrative: Bitter metallic taste; Tiredness; head pressure; flushing; muscle aches; injection site tenderness; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in right arm on 23Feb2021 08:30 (Batch/Lot Number: EN5318) (at the age of 32-years-old) as dose 2, single for COVID-19 immunisation. Medical history included allergies in latex and adhesives. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. The patient was not pregnant at time of vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID, 25 ug) taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks before vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number: EL9265) (at the age of 32-years-old) on 29Jan2021 at 09:00 for COVID-19 immunisation. The patient experienced bitter metallic taste, tiredness, head pressure, flushing, muscle aches and injection site tenderness (for 48 hours) on 25Feb2021 at 12:00, 48 hours post vaccine. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events bitter metallic taste, tiredness, head pressure, flushing, muscle aches was recovering; while outcome of event injection site tenderness was recovered on 27May2021 at 12:00 (48 hours).   No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Bitter metallic taste; Tiredness; head pressure; flushing; muscle aches; injection site tenderness; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in right arm on 23Feb2021 08:30 (Batch/Lot Number: EN5318) (at the age of 32-years-old) as dose 2, single for COVID-19 immunisation. Medical history included allergies in latex and adhesives. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. The patient was not pregnant at time of vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID, 25 ug) taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks before vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number: EL9265) (at the age of 32-years-old) on 29Jan2021 at 09:00 for COVID-19 immunisation. The patient experienced bitter metallic taste, tiredness, head pressure, flushing, muscle aches and injection site tenderness (for 48 hours) on 25Feb2021 at 12:00, 48 hours post vaccine. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events bitter metallic taste, tiredness, head pressure, flushing, muscle aches was recovering; while outcome of event injection site tenderness was recovered on 27May2021 at 12:00 (48 hours).   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash erythematous, Swelling
Clinical narrative: red rash; Soreness; swelling; itching; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 77, unit unknown) received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the left arm on 23Feb2021 at 10:00 (Lot Number: EL9266) as dose 1, single for COVID-19 immunization.  Medical history included sinus infection on an unknown date. The patient was taking unspecified concomitant medications. The patient did not receive other vaccines in four weeks. The patient previously took codeine and experienced allergy. On 24Feb2021 at 08:00 the patient experienced soreness, swelling, red rash and itching. The patient did not receive treatment for the events. The outcome of the events was recovering.    No follow up attempts are possible. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Nausea, Pain, Pyrexia
Clinical narrative: left arm is burning; overall body aches; Chills; Fever; Nausea; Sneezing; This is a spontaneous report from a contactable consumer (patient) via Regulatory Authority.  A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 25Feb2021 08:30 (lot number: EL9266; expiry date: unknown) at the age of 27-years-old, as dose 1, single, for Covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. Concomitant medication included medical marijuana. The patient was not pregnant at the time of vaccination. The vaccine was administered in the hospital. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient has not been tested for COVID-19 since vaccination. On 25Feb2021, at 21:00, the patient's left arm was burning, experienced overall body aches, chills, fever, nausea, and sneezing. The patient did not receive treatment for the events. Outcome of the events was not recovered.  No follow up attempts are possible. No further information is expected.